Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Neuropharmacology|March 13, 2019
Bifunctional opioid receptor ligands as novel analgesicsChristopher W Cunningham, Waleed M Elballa, Stephanie U Vold
Pharmacological Reviews|March 30, 2011
Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin AChristopher W Cunningham, Richard B Rothman, Thomas E Prisinzano
The Journal of Pharmacology and Experimental Therapeutics|December 7, 2005
Discriminative stimulus effects of gamma-hydroxybutyrate: role of training doseWouter Koek, Weibin Chen, Susan L Mercer, et al.
Chemical Research in Toxicology|July 19, 2013
Etoposide catechol is an oxidizable topoisomerase II poisonDavid A Jacob, Elizabeth G Gibson, Susan L Mercer, et al.
Chemical Research in Toxicology|August 18, 2016
Two-Mechanism Model for the Interaction of Etoposide Quinone with Topoisomerase IIαElizabeth G Gibson, McKenzie M King, Susan L Mercer, et al.
Pharmacology, Biochemistry, and Behavior|January 28, 2021
Modern approaches to the development of synthetic cannabinoid receptor probesSavanah L Saldaña-Shumaker, Alexander J Grenning, Christopher W Cunningham
European Journal of Medicinal Chemistry|November 9, 2007
Nitrile analogs of meperidine as high affinity and selective sigma-1 receptor ligandsSusan L Mercer, Jamaluddin Shaikh, John R Traynor, et al.
Future Medicinal Chemistry|March 24, 2011
Utilizing nature as a source of new probes for opioid pharmacologyKimberly M Lovell, Denise S Simpson, Christopher W Cunningham, et al.
Biochemistry|April 29, 2014
Etoposide quinone is a covalent poison of human topoisomerase IIβNicholas A Smith, Jo Ann W Byl, Susan L Mercer, et al.
Chemical Research in Toxicology|December 23, 2017
HU-331 and Oxidized Cannabidiol Act as Inhibitors of Human Topoisomerase IIα and βJames T Wilson, Cole A Fief, Klarissa D Jackson, et al.
Pageof 5